Results 91 to 100 of about 416,233 (177)

Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale

open access: yes, 2010
Percutaneous closure of patent foramen ovale (PFO) has been shown safe and feasible using several devices. The Occlutech Figulla single layer PFO Occluder (FPO) constitutes an alternative to the Amplatzer PFO Occluder (APFO)
Windecker, Stephan   +15 more
core   +1 more source

Recognition of Patau Syndrome (Trisomy 13) Based on Clinical Features in a Resource‐Limited Setting: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Patau syndrome (trisomy 13) is a life‐limiting chromosomal disorder with multiple congenital anomalies. We report a term male neonate with bilateral cleft lip and palate, aplasia cutis congenita, postaxial polydactyly, hypotonia, congenital heart disease, and presumed neonatal sepsis.
Sayed Hussain Amiri   +4 more
wiley   +1 more source

Patent foramen ovale: indications for closure and techniques

open access: yes, 2016
Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved safe in probably a million cases performed worldwide.
Maisano, Francesco   +3 more
core   +1 more source

Finite Element Simulation Analysis of a Nickel-Titanium Alloy Patent Foramen Ovale Occluder

open access: yesZhongguo yiliao qixie zazhi
In this paper, a preliminary stress/strain analysis of the design structure of a nickel-titanium alloy patent foramen ovale occluder is conducted with the finite element simulation analysis method. In the analysis, solid structure modeling is carried out
Juan SHEN, Wei LIU
doaj   +1 more source

Thrombus Metabolism‐Based Molecular Subtyping for Prognostic Risk Stratification in Acute Ischemic Stroke: A Preliminary Study

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
This study identified two metabolically distinct thrombus molecular subtypes in AIS: a lipid metabolism‐enriched subtype (C1) associated with cardioembolic stroke and poor functional outcomes, and a folate metabolism‐enriched subtype (C2) linked to atherothrombotic stroke and better prognosis. A six‐metabolite signature further demonstrated exploratory
Taoyuan Lu   +7 more
wiley   +1 more source

Beware of Bubbles: Coronary Air Embolism During Transcatheter Patent Foramen Ovale Closure [PDF]

open access: yes
Coronary air embolism is a rare and life-threatening side effect of endovascular interventions, mostly due to procedure-related causes. A 51-year-old man presented with a history of multiple transient ischemic attacks. Patent foramen ovale was found, and
Iosif Bikakis   +3 more
core   +1 more source

Cryptogenic Stroke and Patent Foramen Ovale. [PDF]

open access: yes, 2018
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of recurrent paradoxical embolism, has been a matter of ongoing debate for ...
Tobis, Jonathan M   +15 more
core   +2 more sources

Percutaneous Closure of Patent Foramen Ovale in a Patient With Incomplete Cor Triatriatum Sinister: A Case Report

open access: yesJournal of Clinical Ultrasound, Volume 54, Issue 7, Page 1752-1755, September 2026.
We present the case of a 55‐year‐old male who experienced a cryptogenic ischemic stroke, likely due to a patent foramen ovale (PFO) in the setting of an incomplete cor triatriatum sinister (CTS) and a 30 mm GORE Cardioform Septal Occluder was successfully implanted.
Anastasios Apostolos   +8 more
wiley   +1 more source

Percutaneous closure of the patent foramen ovale

open access: yes, 2007
A patent foramen ovale (PFO) is a common finding present in 25% of the population. A relationship between PFO and several clinical conditions such as stroke, migraine, platypnea-orthodeoxia syndrome, neurological decompression illness in divers, high ...
Meier, B, Surmely, J-F
core  

Home - About - Disclaimer - Privacy